KAWASAKI, Japan, Oct 13, 2020 - (JCN Newswire) - Fujitsu Limited and PeptiDream Inc. today announced that the two companies have succeeded in identifying, based on in-silico exploration, stable conformations(1) of a cyclic peptide(2) drug candidate within a 12-hour period. This represents a milestone achieved by utilizing high-performance...